Title: Risk of Ischemic Heart Disease due to Hyperglycemia: A Independent Marker CRP

Authors: Jaswant Kaur, Dr Tejinder Singh, Sonia Chawla, Dr Garima Sehgal, Reshu Tewari

 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.156

Abstract

Background: One of the major complication of diabetes mellitus (DM) is cardiovascular disease, which is the main cause of death in patients of north Indians. Hyperglycemia leads to the risk of inflammation as well as vascular damage through various mechanisms. This study was being conducted to evaluate the role C-Reactive Protein (CRP) as as inflammatory marker in type 2 DM with IHD and type 2 DM without IHD patients.

Methodology: A comparative study was conducted. The present study were assessed the fasting blood glucose and C-reactive protein levels in two groups. Group A comprised of 50 diabetic patients with Ischemic heart disease (IHD) , Group B consist of 50 diabetic patient without IHD. All the patients were selected from Govt. Medical College, Amritsar.

Result: The mean of CRP and Fasting blood glucose (FBS) were significantly (P<0.05) high in type 2 diabetic patient with IHD as compared to type 2 diabetic patient without IHD .

Conclusion: It is concluded that there is significance association between the level of serum CRP and FBS. Moreover, positive correlation between CRP and FBS has been shown that inflammatory marker is the main indicator of insulin resistance which is observed in type 2 DM without IHD patients and with IHD patients. CRP can be used as a marker for diagnosis of early stages of the risk of IHD in type2 diabetic patients.

Keywords: C-Reactive Protein, Diabetes Mellitus, Ischemic heart disease, Fasting blood sugar.

References

  1. Narayan M :  Life time risk for diabetes mellitus in United State. JAMA, 290 (14): 2003;1884-1890.
  2. Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789.
  3. Freeman DJ, et.al: C-reactive protein is an independent predictor of type 2 diabetes in West of Scotland coronary prevention study. Diabetes,2002; 51:1596-1600.
  4. Arnalich F, Hernanz A, Lopez modernelod , et.al: Enhanced acute phaseresponse and oxidative stress in older adults with type 2 diabetes. Horm Metab. Res.2000;32: 407-412.
  5. Abbas Dehgan, Isabella Carddys, Moniek PM, et al. :Genetic variations, C-reactive protein and risk of type 2 diabetes. Diabetes,2005; 70:126-31.
  6. Centers for Disease Control and Prevention. National diabetes statistics report: Estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014
  7. Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil) International journal of epidemiology. 2015;44((1)):68–75. 10.1093/ije/dyu027 [PMC free article] [PubMed]
  8. Camelo LV, Giatti L, Neves JA, Lotufo PA, Bensenor IM, Chor D, et al. Life course socioeconomic position and C-reactive protein: mediating role of health-risk behaviors and metabolic alterations. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) PloS one. 2014;9((10)):e108426. 10.1371/journal.pone.0108426 [PMC free article] [PubMed]
  9. Wild S, Roglic G, SicreeR , et.al :Global prevalance of the diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care,2004; 27: 1047- 53
  10. Dehghan A, Isabella K, et al.: Genetic Variation, C - reactive protein Levels, and Incidence of Diabetes. Diabetes 2007; (56).
  11. Pradhan AD, Cook NR, Buring Je, et.al.:C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler. Thromb.Vasc.Biol.2003;23:650-655.
  12. Nakanishi S, Yamane K,Kamie N, et.al.: Elevated C-reactive protein is a risk factor for type 2 diabetes in Japanese Americans. Diabetes Care,2003;26:2754-2757.
  13. Bell DS: Inflammation, insulin resistance, diabetes and atherosclerosis.. Endocr Pract. 2000, 6: 272-276
  14. Heinrich PC, Castell JV, Andus T: Interleukin 6 and the acute phase response. Biochem J,1990,265:621-636.
  15. Singhania PR, Gupta G, et al.: Inflammatory Biomarkers in Asian Indian Women with Metabolic Syndrome. Food and Nutrition Sciences 2013; 4: 1021-102 Int J Mol Sci.2018 Mar 10;19(3). pii: E802. doi: 10.3390/ijms19030802.

Corresponding Author

Dr Tejinder Singh

Senior Resident, Department of Biochemistry, GMC Amritsar, India